首页|哌拉西林钠他唑巴坦钠联合肺泡灌洗治疗社区获得性肺炎的临床效果观察

哌拉西林钠他唑巴坦钠联合肺泡灌洗治疗社区获得性肺炎的临床效果观察

扫码查看
目的 探讨哌拉西林钠他唑巴坦钠联合肺泡灌洗治疗社区获得性肺炎(CAP)的效果.方法 80 例CAP患者随机分为两组,对照组采用哌拉西林钠他唑巴坦钠治疗,观察组在对照组基础上采用肺泡灌洗治疗,比较两组的治疗效果.结果 治疗后,观察组的咳嗽、咳痰、肺啰音及发热消失时间均短于对照组,CRP、IL-6、PCT水平均低于对照组,PaO2、PaCO2、SO2 水平均优于对照组(P<0.05).结论 哌拉西林钠他唑巴坦钠联合肺泡灌洗可减轻CAP患者的肺部炎性反应,改善血气指标.
Observation on the Clinical Effect of Piperacillin Sodium and Tazobactam Sodium Combined with Alveolar Lavage in the Treatment of Community Acquired Pneumonia
Objective To explore the effect of piperacillin sodium and tazobactam sodium combined with alveolar lavage in the treatment of community acquired pneumonia(CAP).Methods 80 patients with CAP were randomly divided into two groups.The control group was treated with piperacillin sodium and tazobactam sodium,and the observation group was treated with alveolar lavage on the basis of the control group.The therapeutic effects of the two groups were compared.Results After treatment,the disappearance time of cough,expectoration,lung rale and fever in the observation group were shorter than those in the control group,the levels of CRP,IL-6 and PCT were lower than those in the control group,and the levels of PaO2,PaCO2 and SO2 were better than those in the control group(P<0.05).Conclusions Piperacillin sodium and tazobactam sodium combined with alveolar lavage can relieve the pulmonary inflammatory response and improve blood gas indicators of patients with CAP.

Piperacillin sodium and tazobactam sodiumAlveolar lavageCommunity acquired pneumonia

闫平、田文娴

展开 >

郑州大学附属郑州中心医院呼吸与危重症科二病区,河南郑州 450007

哌拉西林钠他唑巴坦钠 肺泡灌洗 社区获得性肺炎

2024

临床医学工程
国家医疗保健器具工程技术研究中心

临床医学工程

影响因子:0.193
ISSN:1674-4659
年,卷(期):2024.31(8)